Early onset of neoplasia in the prostate and skin of mice with tissue-specific deletion of Pten

Stéphanie A. Backman, Danny Ghazarian, Kelvin So, Otto Sanchez, Kay Uwe Wagner, Lothar Hennighausen, Akira Suzuki, Ming Sound Tsao, William B. Chapman, Vuk Stambolic, Tak W. Mak

Research output: Contribution to journalArticle

133 Citations (Scopus)

Abstract

PTEN is a tumor suppressor gene mutated in various advanced human neoplasias, including glioblastomas and prostate, breast, endometrial, and kidney cancers. This tumor suppressor is a lipid phosphatase that negatively regulates cell survival and proliferation mediated by phosphatidylinositol 3-kinase/protein kinase B signaling. Using the Cre-loxP system, we selectively inactivated Pten in murine tissues in which the MMTV-LTR promoter is active, resulting in hyperproliferation and neoplastic changes in Pten-null skin and prostate. These phenotypes had early onset and were completely penetrant. Abnormalities in Pten mutant skin consisted of mild epidermal hyperplasia, whereas prostates from these mice exhibited high-grade prostatic intraepithelial neoplasia (HGPIN) that frequently progressed to focally invasive cancer. These data demonstrate that Pten is an important physiological regulator of growth in the skin and prostate. Further, the early onset of HGPIN in Pten mutant males is unique to this animal model and implicates PTEN mutations in the initiation of prostate cancer. Consistent with high PTEN mutation rates in human prostate tumors, these data indicate that PTEN is a critical tumor suppressor in this organ.

Original languageEnglish (US)
Pages (from-to)1725-1730
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume101
Issue number6
DOIs
StatePublished - Feb 10 2004

Fingerprint

Prostate
Skin
Prostatic Intraepithelial Neoplasia
Neoplasms
Prostatic Neoplasms
Phosphatidylinositol 3-Kinase
Proto-Oncogene Proteins c-akt
Kidney Neoplasms
Mutation Rate
Glioblastoma
Endometrial Neoplasms
Tumor Suppressor Genes
Phosphoric Monoester Hydrolases
Hyperplasia
Cell Survival
Animal Models
Cell Proliferation
Breast Neoplasms
Phenotype
Lipids

ASJC Scopus subject areas

  • General

Cite this

Early onset of neoplasia in the prostate and skin of mice with tissue-specific deletion of Pten. / Backman, Stéphanie A.; Ghazarian, Danny; So, Kelvin; Sanchez, Otto; Wagner, Kay Uwe; Hennighausen, Lothar; Suzuki, Akira; Tsao, Ming Sound; Chapman, William B.; Stambolic, Vuk; Mak, Tak W.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 101, No. 6, 10.02.2004, p. 1725-1730.

Research output: Contribution to journalArticle

Backman, SA, Ghazarian, D, So, K, Sanchez, O, Wagner, KU, Hennighausen, L, Suzuki, A, Tsao, MS, Chapman, WB, Stambolic, V & Mak, TW 2004, 'Early onset of neoplasia in the prostate and skin of mice with tissue-specific deletion of Pten', Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 6, pp. 1725-1730. https://doi.org/10.1073/pnas.0308217100
Backman, Stéphanie A. ; Ghazarian, Danny ; So, Kelvin ; Sanchez, Otto ; Wagner, Kay Uwe ; Hennighausen, Lothar ; Suzuki, Akira ; Tsao, Ming Sound ; Chapman, William B. ; Stambolic, Vuk ; Mak, Tak W. / Early onset of neoplasia in the prostate and skin of mice with tissue-specific deletion of Pten. In: Proceedings of the National Academy of Sciences of the United States of America. 2004 ; Vol. 101, No. 6. pp. 1725-1730.
@article{29d8fc34dfdd47a1862fbd88b376b32c,
title = "Early onset of neoplasia in the prostate and skin of mice with tissue-specific deletion of Pten",
abstract = "PTEN is a tumor suppressor gene mutated in various advanced human neoplasias, including glioblastomas and prostate, breast, endometrial, and kidney cancers. This tumor suppressor is a lipid phosphatase that negatively regulates cell survival and proliferation mediated by phosphatidylinositol 3-kinase/protein kinase B signaling. Using the Cre-loxP system, we selectively inactivated Pten in murine tissues in which the MMTV-LTR promoter is active, resulting in hyperproliferation and neoplastic changes in Pten-null skin and prostate. These phenotypes had early onset and were completely penetrant. Abnormalities in Pten mutant skin consisted of mild epidermal hyperplasia, whereas prostates from these mice exhibited high-grade prostatic intraepithelial neoplasia (HGPIN) that frequently progressed to focally invasive cancer. These data demonstrate that Pten is an important physiological regulator of growth in the skin and prostate. Further, the early onset of HGPIN in Pten mutant males is unique to this animal model and implicates PTEN mutations in the initiation of prostate cancer. Consistent with high PTEN mutation rates in human prostate tumors, these data indicate that PTEN is a critical tumor suppressor in this organ.",
author = "Backman, {St{\'e}phanie A.} and Danny Ghazarian and Kelvin So and Otto Sanchez and Wagner, {Kay Uwe} and Lothar Hennighausen and Akira Suzuki and Tsao, {Ming Sound} and Chapman, {William B.} and Vuk Stambolic and Mak, {Tak W.}",
year = "2004",
month = "2",
day = "10",
doi = "10.1073/pnas.0308217100",
language = "English (US)",
volume = "101",
pages = "1725--1730",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "6",

}

TY - JOUR

T1 - Early onset of neoplasia in the prostate and skin of mice with tissue-specific deletion of Pten

AU - Backman, Stéphanie A.

AU - Ghazarian, Danny

AU - So, Kelvin

AU - Sanchez, Otto

AU - Wagner, Kay Uwe

AU - Hennighausen, Lothar

AU - Suzuki, Akira

AU - Tsao, Ming Sound

AU - Chapman, William B.

AU - Stambolic, Vuk

AU - Mak, Tak W.

PY - 2004/2/10

Y1 - 2004/2/10

N2 - PTEN is a tumor suppressor gene mutated in various advanced human neoplasias, including glioblastomas and prostate, breast, endometrial, and kidney cancers. This tumor suppressor is a lipid phosphatase that negatively regulates cell survival and proliferation mediated by phosphatidylinositol 3-kinase/protein kinase B signaling. Using the Cre-loxP system, we selectively inactivated Pten in murine tissues in which the MMTV-LTR promoter is active, resulting in hyperproliferation and neoplastic changes in Pten-null skin and prostate. These phenotypes had early onset and were completely penetrant. Abnormalities in Pten mutant skin consisted of mild epidermal hyperplasia, whereas prostates from these mice exhibited high-grade prostatic intraepithelial neoplasia (HGPIN) that frequently progressed to focally invasive cancer. These data demonstrate that Pten is an important physiological regulator of growth in the skin and prostate. Further, the early onset of HGPIN in Pten mutant males is unique to this animal model and implicates PTEN mutations in the initiation of prostate cancer. Consistent with high PTEN mutation rates in human prostate tumors, these data indicate that PTEN is a critical tumor suppressor in this organ.

AB - PTEN is a tumor suppressor gene mutated in various advanced human neoplasias, including glioblastomas and prostate, breast, endometrial, and kidney cancers. This tumor suppressor is a lipid phosphatase that negatively regulates cell survival and proliferation mediated by phosphatidylinositol 3-kinase/protein kinase B signaling. Using the Cre-loxP system, we selectively inactivated Pten in murine tissues in which the MMTV-LTR promoter is active, resulting in hyperproliferation and neoplastic changes in Pten-null skin and prostate. These phenotypes had early onset and were completely penetrant. Abnormalities in Pten mutant skin consisted of mild epidermal hyperplasia, whereas prostates from these mice exhibited high-grade prostatic intraepithelial neoplasia (HGPIN) that frequently progressed to focally invasive cancer. These data demonstrate that Pten is an important physiological regulator of growth in the skin and prostate. Further, the early onset of HGPIN in Pten mutant males is unique to this animal model and implicates PTEN mutations in the initiation of prostate cancer. Consistent with high PTEN mutation rates in human prostate tumors, these data indicate that PTEN is a critical tumor suppressor in this organ.

UR - http://www.scopus.com/inward/record.url?scp=10744233783&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10744233783&partnerID=8YFLogxK

U2 - 10.1073/pnas.0308217100

DO - 10.1073/pnas.0308217100

M3 - Article

C2 - 14747659

AN - SCOPUS:10744233783

VL - 101

SP - 1725

EP - 1730

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 6

ER -